Arkolith/Insider Trading/CLSD/Form 4

Ciulla Thomas

Chief Medical OfficerClearside Biomedical, Inc. (CLSD) · full profile →Form 4 · filed Jan 20, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$20K
Net Open-Market Flow
-$20K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 20, 2023Sell(S)14K$1.47$20K292K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-004278) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML